~~<i id='8062E2D4D1'><strike id='8062E2D4D1'><tt id='8062E2D4D1'><pre id='8062E2D4D1'></pre></tt></strike></i>~~

Home» focus» hotspot

hotspot

author：Wikipedia 2025-09-29 14:59:30 Page View：128

MADRID — Merck is paying billions of dollars to partner with Daiichi Sankyo on a series of cancer drugs, underscoring the excitement around targeted chemotherapy treatments.

The deal includes a $4 billion upfront payment and an additional $1.5 billion over the next two years. Up to $16.5 billion more is on the table depending on the success of the drugs in development.

The announcement on Thursday night in the United States came on the eve of one the cancer field’s biggest annual conferences, the European Society for Medical Oncology Congress, being held this year in Madrid.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Make 'food is medicine' a key part of White House nutrition meeting
Next article： Medical records are filled with copy

comprehensive

The cancer drug shortage isn’t new — and neither are the solutions

PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

Ask STAT: What do you want to know about ChatGPT in medicine?

AdobeFrommedicalnote-takingtoanalyzingX-raysandmammograms,newartificialintelligencetoolsareswiftlyga

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

New guidelines on severe brain injury complicate already difficult decisions

AdobeWhensomeonesustainsaseriousbraininjuryandisunresponsive,howsooncandoctorssaywhetherheorshehasac

WSS

hotspot

hotspot

explore

comprehensive

New guidelines on severe brain injury complicate already difficult decisions